Obermatt
See Similar Stocks →

Anavex Life Sciences

NSQ:AVXL · US0327973006
BiotechnologySmall

360° View

no current rank
Price/Sales100
Price/Earnings59
Price/Book65
Dividend Yield—
Revenue Growth—
Profit Growth94
Capital Growth83
TSR 52w4
Leverage80
Liquidity—
Refinancing41
Combined—
Analyst Opinions100
Pro Holdings37
Opinion Changes50
Market Pulse42

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2004
Employees43
Websiteanavex.com
ISINUS0327973006
Last UpdateApr 2, 2026
Index & Theme
Pain ManagementNeurologyGeneticsPsychiatryChronic DiseasesNeuroscienceCentral Nervous SystemOncologyBiopharmaBiotechnologyTherapeutics

Description

Anavex Life Sciences Corp. (Anavex) operates as a clinical stage biopharmaceutical company. The company engages in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with high unmet…

Similar Stocks

The companies this stock is ranked against.

Compare Anavex Life Sciences with its peers
MapLight Therapeutics
NSQ:MPLT
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Taysha Gene Therapies
NSQ:TSHA
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Protagonist Therapeutics
NMQ:PTGX
27
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Sellas Life Sciences
NAQ:SLS
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Voyager Therapeutics
NSQ:VYGR
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Acumen Pharmaceuticals
NSQ:ABOS
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →